Home / Secukinumab / Austria
AT ATC L04AC10 · updated 2 Nov 2026
Secukinumab shortage in Austria
Is there a Secukinumab shortage in Austria?
Yes. As of 2 Nov 2026, 1 Secukinumab product is reported short in Austria, the first since 4 Aug 2023. No return date has been given. Main reason: increased demand.
Also short in Belgium. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Cosentyx 150 mg Injektionslösung in einer Fertigspritze, 1 Stück | Novartis Europharm Limited | 4 Aug 2023 | not given | Increased demand Erhöhter Mehrbedarf |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).